Sign in

AACR Journals

@aacrjournals.bsky.social
450 followers 56 following 983 posts

The American Association for Cancer Research’s 10 peer-reviewed journals provide a renowned, respected forum for publishing the most innovative cancer science, encompassing the full spectrum of basic, translational, clinical, and epidemiological research.

PostsRepliesMedia
AACR Journals @aacrjournals.bsky.social · 2h
Read the October issue of Molecular Cancer Research: buff.ly/N8xsov4
000
AACR Journals @aacrjournals.bsky.social · 8h
This collection of recent articles from the AACR journals highlights exciting basic, translational, and clinical advances in pancreatic cancer research. Read more: buff.ly/kSf0UjZ
000
AACR Journals @aacrjournals.bsky.social · 9h
Read the October 1 issue of Clinical Cancer Research: buff.ly/ApxRHhc
000
AACR Journals @aacrjournals.bsky.social · 03/10/2026
Read the October issue of Cancer Epidemiology, Biomarkers & Prevention: buff.ly/cSP42rg
000
AACR Journals @aacrjournals.bsky.social · 03/10/2026
Read the Clinical Hemato-Oncology article collection, showcasing recent Blood Cancer Discovery content of broadest relevance to clinical hemato-oncology research and practice, encompassing biology-informed prognostication, new therapies, clinical trials, and more. buff.ly/Lymr7Rx
000
AACR Journals @aacrjournals.bsky.social · 03/10/2026
Read the October issue of Cancer Prevention Research: buff.ly/mqrMj77
001
AACR Journals @aacrjournals.bsky.social · 03/10/2026
Read the October issue of Cancer Discovery: buff.ly/vfDvoxr
000
AACR Journals @aacrjournals.bsky.social · 03/10/2026
Read: "The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells" from the most recent issue of Blood Cancer Discovery. buff.ly/zdYtxJb
010
AACR Journals @aacrjournals.bsky.social · 03/10/2026
Read: Longitudinal Association of Quantitative Background Parenchymal Enhancement with Breast Cancer Risk among Women with BRCA1/2 Pathogenic Variants, in Cancer Epidemiology, Biomarkers & Prevention. buff.ly/wIMbXq8
000
AACR Journals @aacrjournals.bsky.social · 02/10/2026
In Clinical Cancer Research, read the Phase 1 Study: Tumoral and Systemic Immune Correlates of Response to Concurrent Pembrolizumab and Chemoradiotherapy in HNSCC (NCT02775812). buff.ly/7wmAjZm
010
AACR Journals @aacrjournals.bsky.social · 01/10/2026
Read the recently updated Myeloma article collection from Blood Cancer Discovery: buff.ly/CnLyN2M
000
AACR Journals @aacrjournals.bsky.social · 01/10/2026
Working on a manuscript? Our presubmission process is easier than ever! ➡️Select a journal and log into the submission system buff.ly/hHebvNv ➡️Choose "presubmission" ➡️Provide a title, abstract, and one supporting file
000
AACR Journals @aacrjournals.bsky.social · 01/10/2026
Read the Phase 2 Study: Atezolizumab and Varlilumab (CDX-1127) with or without Cobimetinib in Previously-treated Unresectable Biliary Tract Cancer (NCT4941287), in Clinical Cancer Research. buff.ly/czHhg2i
000
AACR Journals @aacrjournals.bsky.social · 01/10/2026
Read: Clinical Validation of a Multiplex Urine Biomarker Assay for Surveillance of Recurrent Bladder Cancer (NCT03193515), in Clinical Cancer Research. buff.ly/Mc8fDhe
000
AACR Journals @aacrjournals.bsky.social · 30/09/2026
Not only do AACR Members receive a 10% discount on publishing fees, but some AACR scientific working groups offer additional discounts on top of this. Learn more: buff.ly/6qmKLPX
000
AACR Journals @aacrjournals.bsky.social · 30/09/2026
Read the Phase 1 Study in Clinical Cancer Research: Comparing Second- vs. Third-Generation L1CAM CAR T cells for R/R Neuroblastoma (ENCIT-01; NCT02311621). buff.ly/3TwOAyz
000
AACR Journals @aacrjournals.bsky.social · 30/09/2026
Read: "LY3410738, a Covalent Inhibitor of Mutant IDH1/2, Is Effective in Acute Myeloid Leukemia Preclinical Models" from the most recent issue of Blood Cancer Discovery. buff.ly/WESv32G
000
AACR Journals @aacrjournals.bsky.social · 29/09/2026
From the September issue of Molecular Cancer Research: Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer ➡️Read the article: buff.ly/yPf4gFs
011
AACR Journals @aacrjournals.bsky.social · 28/09/2026
Energy Balance–Related Factors and Direct Tumor–Adipocyte Contact in Colorectal Cancer: Etiologic Insights from the Population-Based Netherlands Cohort Study, published in Cancer Epidemiology, Biomarkers & Prevention. buff.ly/Gd1h93f
000
AACR Journals @aacrjournals.bsky.social · 28/09/2026
Read the Phase 2 Study: Camrelizumab, Apatinib, and Radiotherapy in Locally Advanced, Unresectable HCC (ChiCTR2000035052), in Clinical Cancer Research. buff.ly/2Nybfmw
000
AACR Journals @aacrjournals.bsky.social · 28/09/2026
In the clip below, Steven Kregel, PhD, recipient of the Molecular Cancer Research Award for Outstanding Journal Article, discusses how gaps in existing mouse models motivated him to develop new humanized systems. Watch the interview: buff.ly/WDpE5kx @stevekregel.bsky.social
011
AACR Journals @aacrjournals.bsky.social · 28/09/2026
Read the new Pancreatic Cancer article collection, highlighting exciting basic, translational, and clinical advances in pancreatic cancer research. buff.ly/kSf0UjZ #AACRpan26
110
AACR Journals @aacrjournals.bsky.social · 27/09/2026
Read the Phase 2 Study: Biomarker Analysis from Patients with mPDAC Treated with TGFβ Antibody NIS793 (NCT04390763), in Clinical Cancer Research. buff.ly/8K6AIGz
000
AACR Journals @aacrjournals.bsky.social · 27/09/2026
Read the Phase 2 Study in Clinical Cancer Research: Metformin and Pembrolizumab Treatment in R/M HNSCC (NCT04414540). buff.ly/lj7yAOU
000
AACR Journals @aacrjournals.bsky.social · 27/09/2026
Read the new Pancreatic Cancer article collection, highlighting exciting basic, translational, and clinical advances in pancreatic cancer research. buff.ly/kSf0UjZ #AACRpan26
100
AACR Journals @aacrjournals.bsky.social · 27/09/2026
Sign up to receive alerts directly to your inbox to keep up with the latest published issues: buff.ly/MPqGjG9
000
AACR Journals @aacrjournals.bsky.social · 27/09/2026
Learn more about Nina Steele, recipient of the 2026 Clinical Cancer Research Early Career Award, who will be presenting on extracting mechanisms of cell cross-talk using spatial and single-cell multiomics at #AACRpan26. buff.ly/2hKXK2D
011
AACR Journals @aacrjournals.bsky.social · 27/09/2026
Attending #AACRpan26? Meet with Michele Hartsough, PhD, Senior Editor, today from 7:15–8:15 AM during the “Meet the Expert” Roundtables Session to learn about opportunities for publication in the Journals.
000
AACR Journals @aacrjournals.bsky.social · 26/09/2026
Attending #AACRpan26? Meet with Michele Hartsough, PhD, Senior Editor, tomorrow from 7:15–8:15 AM during the “Meet the Expert” Roundtables Session to learn about opportunities for publication in the Journals.
000
AACR Journals @aacrjournals.bsky.social · 26/09/2026
In Clinical Cancer Research: Network Integrated Platform for Clinical Trials Navigation from the New South Wales Early Phase Clinical Trials Alliance (ACTRN12623000108617). buff.ly/BkNzPmV
000
AACR Journals @aacrjournals.bsky.social · 26/09/2026
Read the abstracts from the AACR Special Conference in Cancer Research: Advances in Pancreatic Cancer Research in this supplement to the September 15 issue of Cancer Research: buff.ly/dDKDmMP #AACRpan26
000
AACR Journals @aacrjournals.bsky.social · 26/09/2026
Read the Cancer Research Resources article: Mapping the Subtype-Specific PARP1 ADP-Ribosylated Proteome in Breast Cancer Cells, in Molecular Cancer Research buff.ly/qfpVBQc
000
AACR Journals @aacrjournals.bsky.social · 26/09/2026
Read the new Pancreatic Cancer article collection, highlighting exciting basic, translational, and clinical advances in pancreatic cancer research. buff.ly/kSf0UjZ #AACRpan26
000
AACR Journals @aacrjournals.bsky.social · 26/09/2026
Read the recent Cancer Discovery review article by #AACRpan26 Conference Cochair Eileen M. O’Reilly, “Pancreatic Cancer: Translating Tumor Biology into Actionability.” buff.ly/PCng7ti #OpenAccess
000
AACR Journals @aacrjournals.bsky.social · 26/09/2026
When you submit to an AACR Journal, you'll benefit from rapid decision and publication times. Learn more about the Manuscript Turnaround Guarantee for Active AACR Members: buff.ly/RF6S0Bu
010
AACR Journals @aacrjournals.bsky.social · 26/09/2026
Michele Hartsough, PhD, Senior Editor, is attending #AACRpan26 and would love to hear about your research. Connect with her to discuss publishing opportunities in the Journals.
000
AACR Journals @aacrjournals.bsky.social · 26/09/2026
Read the recently updated Myeloma Collection, showcasing impactful articles published in Blood Cancer Discovery: buff.ly/CnLyN2M #IMS26
000
AACR Journals @aacrjournals.bsky.social · 26/09/2026
Read the Tumor Microenvironment article collection that highlights recent advances characterizing the complex interactions and spatial associations between cell types in the TME and identifies potential pathways for improved cancer therapies directed against the TME. buff.ly/kFKsAFh #JCA85
000
AACR Journals @aacrjournals.bsky.social · 26/09/2026
Read the Cancer Health Disparities article collection, highlighting studies that identify and chart paths forward for addressing cancer health disparities and make clear the need for more inclusive approaches to basic, translational, and clinical cancer research. buff.ly/G7beFXI #WCC2026
010
AACR Journals @aacrjournals.bsky.social · 25/09/2026
Visit the AACR table at #AACRpan26 and pick up the AACR Journals brochure to read the latest groundbreaking research published in the Journals.
000
AACR Journals @aacrjournals.bsky.social · 25/09/2026
Read the collection, Advances in Targeted Protein Degradation: PROTACs and Molecular Glues buff.ly/xdWDulw This collection features recent research and review articles highlighting key advances in PROTAC and molecular glue development.
010
AACR Journals @aacrjournals.bsky.social · 25/09/2026
Read this recently published In Focus, “Targeting RAS for Pancreatic Cancer Interception,” in advance of #AACRpan26: buff.ly/DSyBulv
010
AACR Journals @aacrjournals.bsky.social · 25/09/2026
Read the recently updated Myeloma Collection, showcasing impactful articles published in Blood Cancer Discovery: buff.ly/CnLyN2M #IMS26
000
AACR Journals @aacrjournals.bsky.social · 25/09/2026
Read: "RAS Pathway Activation and Microenvironmental Adaptation as Hallmarks of Myeloid Sarcoma" from this month's issue of Blood Cancer Discovery. buff.ly/O9S6B09
001
AACR Journals @aacrjournals.bsky.social · 25/09/2026
Read this Blood Cancer Discovery review by #IMS26 plenary speaker Saad Z. Usmani, “First-line Therapy in Newly Diagnosed Multiple Myeloma.” buff.ly/fQ7gatp @szusmani.bsky.social
000
AACR Journals @aacrjournals.bsky.social · 25/09/2026
In this clip, Nina Steele, recipient of the Clinical Cancer Research Early Career Award, talks about the motivation & foundation for her study on an scRNA-seq atlas of the human pancreas. Watch the interview: buff.ly/lIYIjMX
021
Reposted by AACR Journals
ACIR @acir-org.bsky.social · 25/09/2026
Qing and Ghorani et al. explored mechanisms of secondary resistance (2°R) to therapy (Treg depletion via anti-CD25 mAb + GM-CSF-expressing tumor cell vaccine) in B16 tumor- bearing mice.  @aacrjournals.bsky.social bit.ly/4h9JjA1
001
AACR Journals @aacrjournals.bsky.social · 25/09/2026
Read this Blood Cancer Discovery research brief by #IMS26 speakers Rahul Banerjee, Doris Hansen, and Surbhi Sidana, “Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium.” buff.ly/5TOvRE1 @rahulbanerjeemd.bsky.social
000
AACR Journals @aacrjournals.bsky.social · 25/09/2026
Read this recent Blood Cancer Discovery research article by Tom Cupedo, "Spatial profiling reveals a distinct MM tumor niche," who will be presenting his work at the Normal and Malignant B Lymphocytes Symposium. buff.ly/RDfME0t
020
AACR Journals @aacrjournals.bsky.social · 25/09/2026
Read this recent Blood Cancer Discovery spotlight by #IMS26 speaker Rahul Banerjee, “Sequenced, Not Stirred: Positioning CAR T and Bispecific Antibody Therapy in Multiple Myeloma.” buff.ly/pnAnzRr @rahulbanerjeemd.bsky.social
011